Microtissues®

Summary

Published in ACS Biomaterials Science & Engineering (2024), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Li, Zhihua, et al. Ultrastable Iodinated Oil-Based Pickering Emulsion Enables Locoregional Sustained Codelivery of Hypoxia Inducible Factor-1 Inhibitor and Anticancer Drugs for Tumor Combination Chemotherapy

🧬 Oncology

Ultrastable Iodinated Oil-Based Pickering Emulsion Enables Locoregional Sustained Codelivery of Hypoxia Inducible Factor-1 Inhibitor and Anticancer Drugs for Tumor Combination Chemotherapy

ACS Biomaterials Science & Engineering 2024 Li, Zhihua, et al
Cite as: Li, Zhihua, et al. Ultrastable Iodinated Oil-Based Pickering Emulsion Enables Locoregional Sustained Codelivery of Hypoxia Inducible Factor-1 Inhibitor and Anticancer Drugs for Tumor Combination Chemotherapy. ACS Biomaterials Science & Engineering (2024). doi:10.1021/acsbiomaterials.3c01887 doi.org/10.1021/acsbiomaterials.3c01887

Research Overview

Tumor hypoxia drives drug resistance, but sustained delivery systems able to carry high loads of hypoxia-inducible factor-1 inhibitors have been scarce. This study developed an ultrastable iodinated oil-based Pickering emulsion for locally sustained co-delivery of the HIF-1 inhibitor acriflavine together with doxorubicin.

The emulsion injected easily for intratumoral administration, was radiopaque for in vivo imaging, remained physically stable for over a month, and released both hydrophilic drugs over the long term — combining chemotherapy with hypoxia-pathway inhibition in a single locally administered formulation.

Key Discoveries

  • Pickering emulsion co-delivered HIF-1 inhibitor acriflavine with doxorubicin intratumorally
  • Physical stability exceeded one month with long-term sustained release of both drugs
  • Radiopacity from the iodinated oil enabled in vivo imaging of the depot